1-Boc-4-哌啶甲酸乙酯 | 135716-09-5

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 1-Boc-4-哌啶甲酸乙酯
• 中文别名: 叔丁基4-(2-乙氧基-2-氧代乙基)哌啶-1-甲酸叔丁酯；4-(2-乙氧基-2-氧代乙基)哌啶-1-甲酸叔丁酯；N-BOC-4-哌啶乙酸乙酯；1-BOC-4-哌啶乙酸乙酯；1-BOC-4-哌啶甲酸乙酯
• 英文名称: tert-butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate
• 英文别名: t-butyl 4-ethoxycarbonylmethyl-piperidine-1-carboxylate；t-butyl 4-(2-ethoxy-2-oxoethyl)tetrahydropyridine-1(2H)-carboxylate
• CAS: 135716-09-5
• 化学式: C₁₄H₂₅NO₄
• mdl: MFCD08275143
• 分子量: 271.357
• InChiKey: PQEXLIRUMIRSAL-UHFFFAOYSA-N

物化性质

• 熔点：
  19.68° C (Predicted)
• 沸点：
  339.2±15.0 °C(Predicted)
• 密度：
  1.048±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.857
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933399090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  | 室温 |

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Ethyl N-BOC-piperidine-4-acetate
Synonyms: tert-butyl 4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl N-BOC-piperidine-4-acetate
CAS number: 135716-09-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C14H25NO4
Molecular weight: 271.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-Boc-4-哌啶甲酸乙酯 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 生成 N-Boc-4-哌啶乙醇
  参考文献：
  名称：

  具有（2R）-2-[（（1R）-3,3-二氟环戊基] -2-羟基苯基乙酰胺结构的毒蕈碱M（3）受体拮抗剂。第2部分。

  摘要：

  进行了我们原始毒蕈碱型M（3）受体拮抗剂1的胺部分的优化，以鉴定出优于1的M（3）受体拮抗剂。对氮原子上带有疏水取代基的各种二胺部分的化合物进行了筛选。 M（3）受体的结合亲和力和M（3）超过M（1）和M（2）受体的选择性。该过程导致了4-氨基哌啶酰胺（2l），其K（i）值为5.1 nM，M（3）受体的选择性比M（2）受体大46倍。通过插入间隔基或将烷基引入胺部分进一步2l衍生化，从而鉴定出K（i）值为3的4-（氨基乙基）哌啶酰胺2l-b。

  DOI：

  10.1016/s0960-894x(03)00350-0
• 作为产物：
  描述：

  叔丁基 4-(2-乙氧基-2-氧代亚乙基)哌啶-1-羧酸 在 palladium on activated charcoal 、 氢气 作用下， 以 乙醇 为溶剂， 反应 5.0h， 生成 1-Boc-4-哌啶甲酸乙酯
  参考文献：
  名称：

  烯烃二羰基化合物的催化，对映选择性和高度化学选择性溴环化

  摘要：

  优先选择：胺-硫代氨基甲酸酯催化剂可介导烯烃1,3-二羰基化合物的简便，高效和高度对映选择性溴环化。在双功能催化剂的存在下，溴化反应是化学选择性地发生在烯烃部分，而不是发生在羰基单元α位的碳原子上。

  DOI：

  10.1002/anie.201304107
• 作为试剂：
  描述：

  4-哌啶乙酸乙酯 、 (3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl methanesulfonate 在 caesium carbonate 、 1-Boc-4-哌啶甲酸乙酯 、 三氟乙酸 作用下， 以 乙腈 为溶剂， 以46 %的产率得到ethyl 2-(1-((3-(4-cyanophenyl)-4,5-dihydroisoxazol-5-yl)methyl)piperidin-4-yl)acetate
  参考文献：
  名称：

  A general chemical principle for creating closure-stabilizing integrin inhibitors

  摘要：

  DOI：

  10.1016/j.cell.2022.08.008

文献信息

• HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS
  申请人：SUVEN LIFE SCIENCES LIMITED

  公开号：US20140187581A1

  公开（公告）日：2014-07-03

  The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT 4 receptors.

  本发明涉及式(I)的新化合物，以及它们的药用盐和含有它们的组合物。 本发明还涉及制备上述新化合物的方法，以及它们的药用盐。式(I)的化合物在治疗与5-HT 4 受体相关的各种疾病中是有用的。
• METALLO-BETA-LACTAMASE INHIBITORS
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20160333021A1

  公开（公告）日：2016-11-17

  The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.

  本发明涉及式(I)的化合物，这些化合物是金属β-内酰胺酶抑制剂，以及这些化合物的合成和与β-内酰胺类抗生素一起用于克服耐药性的用途。
• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
  申请人：Arvinas, Inc.

  公开号：US20180099940A1

  公开（公告）日：2018-04-12

  The present disclosure relates to bifunctional compounds, which find utility to degrade and (inhibit) Androgen Receptor. In particular, the present disclosure is directed to compounds, which contain on one end a cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds Androgen Receptor, such that Androgen Receptor is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of Androgen Receptor. The present disclosure exhibits a broad range of pharmacological activities associated with compounds according to the present disclosure, consistent with the degradation/inhibition of Androgen Receptor.

  本公开涉及双功能化合物，其用于降解和（抑制）雄激素受体。具体而言，本公开涉及包含一端结合到E3泛素连接酶的谷氨酰腺苷环配体，另一端结合到雄激素受体的部分的化合物，使得雄激素受体与泛素连接酶靠近，以实现雄激素受体的降解（和抑制）。本公开展示了与根据本公开涉及的化合物相关的广泛的药理活性范围，与雄激素受体的降解/抑制一致。
• Synthesis and pharmacological characterization of novel N -( trans -4-(2-(4-(benzo[ d ]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics
  作者：Xiao-Wen Chen、Yuan-Yuan Sun、Lei Fu、Jian-Qi Li

  DOI：10.1016/j.ejmech.2016.07.038

  日期：2016.11

  benzisothiazolylpiperazine derivatives combining potent dopamine D2 and D3, and serotonin 5-HT1A and 5-HT2A receptor properties were synthesized and evaluated for their potential antipsychotic properties. The most-promising derivative was 9j. The unique pharmacological features of 9j were a high affinity for D2, D3, 5-HT1A, and 5-HT2A receptors, together with a 20-fold selectivity for the D3 versus D2 subtype, and

  合成了一系列结合强力多巴胺D 2和D 3以及5-羟色胺5-HT 1A和5-HT 2A受体特性的新型苯并异噻唑基哌嗪衍生物，并评估了其潜在的抗精神病特性。最有前途的导数是9j。的独特的药理学特征9J是为d的高亲和性2，d 3，5-HT 1A和5-HT 2A受体，与用于d 20倍的选择性一起3与d 2亚型，和对于低亲和力毒蕈碱M 1（降低抗胆碱能副作用的风险）和hERG通道（降低QT间期延长的发生率）。在动物行为模型中，9j抑制了苯环利定的运动刺激作用，阻断了条件回避反应，并改善了大鼠的新型物体识别测试中的认知缺陷。9j表现出较低的僵化潜能，与利培酮的结果一致。另外，在大鼠中检测到了良好的9j脑渗透率。这些研究表明9j是潜在的非典型抗精神病药候选物。
• Substituted pyrazoles as p38 kinase inhibitors
  申请人：G. D. Searle & Company

  公开号：US06423713B1

  公开（公告）日：2002-07-23

  A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula IA wherein R1, R2, R3 and R4 are as described in the specification.

  描述了一类吡唑衍生物，用于治疗p38激酶介导的疾病。特别感兴趣的化合物由下式IA定义： 其中R1、R2、R3和R4如规范中所述。